Roche

Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Fierce Pharma
Sun, 09/15/24 - 06:17 pm
Roche
Genentech
Ocrevus
MS
Ocrevus Zunovo
FDA approves Roche’s Tecentriq Hybreza for cancer
Yahoo Finance
Fri, 09/13/24 - 09:33 am
Roche
FDA
Tecentriq Hybreza
cancer
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Fierce Biotech
Wed, 09/11/24 - 11:15 pm
Roche
obesity
CT-388
Carmot Therapeutics
Roche ramps up R&D with $1.4B Swiss facility
Fierce Biotech
Wed, 09/11/24 - 11:55 am
Roche
R&D
Switzerland
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
Genentech's cancer restructure was made 'for scientific reasons': exec
Fierce Biotech
Tue, 09/10/24 - 08:44 am
Genentech
Roche
restructuring
Huntington’s disease R&D is regaining ground after several disappointments
Pharma Voice
Mon, 09/9/24 - 10:44 am
Huntington's disease
uniQure
Prilenia Therapeutics
Wave
Roche
Ionis Pharmaceuticals
Vico Therapeutics
ArsenalBio raises $325M in one of the year’s largest biotech funding rounds
BioPharma Dive
Wed, 09/4/24 - 11:46 am
Arsenal Bio
funding
biotech
cell therapy
ovarian cancer
kidney cancer
Roche
Bristol Myers Squibb
Roche trumpets new fenebrutinib data in relapsing MS
Pharmaphorum
Wed, 09/4/24 - 11:25 am
Roche
clinical trials
fenebrutinib
MS
relapsing multiple sclerosis
WHO invites makers of mpox tests for emergency review in push for rapid access
Reuters
Thu, 08/29/24 - 06:07 pm
WHO
mpox
diagnostics
Roche
LabCorp
Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology research unit
Fierce Biotech
Wed, 08/28/24 - 11:36 am
Genentech
Roche
layoffs
California
Roche tops pharma rivals for reputation among rare disease patient groups
Medical Marketing and Media
Wed, 08/21/24 - 11:39 am
Roche
reputation
Rare Diseases
Biomarin
Amgen
BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg
Fierce Biotech
Wed, 08/21/24 - 11:31 am
Biomarin
R&D
Roche
Amgen
Roche says it is working to enhance lab testing capacity for mpox worldwide
Reuters
Tue, 08/20/24 - 10:29 am
Roche
diagnostics
mpox
J&J and Roche are the strongest companies in the biopharma industry, says S&P Global
Fierce Pharma
Wed, 08/14/24 - 11:20 am
S&P Global
JNJ
Roche
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Big Pharma
JNJ
AbbVie
Pfizer
Roche
Eli Lilly
Novo Nordisk
Merck
Roche considering divesting $1.9 bln cancer data startup, FT reports
Reuters
Wed, 08/7/24 - 11:24 am
Roche
Flatiron Health
cancer
oncology
Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech
Fierce Biotech
Tue, 08/6/24 - 11:34 am
Sangamo Therapeutics
Roche
Genentech
neurodegenerative disease
Ionis axes eye disease from targets of Roche-partnered prospect after data disappoint
Fierce Biotech
Thu, 08/1/24 - 11:50 am
Ionis Pharmaceuticals
Roche
age-related macular degeneration
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
BioPharma Dive
Thu, 07/25/24 - 10:05 pm
Roche
obesity
Carmot Therapeutics
CT-388
CT-996

Pages